508 related articles for article (PubMed ID: 29480189)
21. Polymorphisms of CR1, CLU and PICALM confer susceptibility of Alzheimer's disease in a southern Chinese population.
Chen LH; Kao PY; Fan YH; Ho DT; Chan CS; Yik PY; Ha JC; Chu LW; Song YQ
Neurobiol Aging; 2012 Jan; 33(1):210.e1-7. PubMed ID: 22015308
[TBL] [Abstract][Full Text] [Related]
22. Implication of common and disease specific variants in CLU, CR1, and PICALM.
Ferrari R; Moreno JH; Minhajuddin AT; O'Bryant SE; Reisch JS; Barber RC; Momeni P
Neurobiol Aging; 2012 Aug; 33(8):1846.e7-18. PubMed ID: 22402018
[TBL] [Abstract][Full Text] [Related]
23. Segmented Linear Mixed Model Analysis Reveals Association of the APOEɛ4 Allele with Faster Rate of Alzheimer's Disease Dementia Progression.
Chen XR; Shao Y; Sadowski MJ;
J Alzheimers Dis; 2021; 82(3):921-937. PubMed ID: 34120907
[TBL] [Abstract][Full Text] [Related]
24. Integration of Multilocus Genetic Risk into the Default Mode Network Longitudinal Trajectory during the Alzheimer's Disease Process.
Su F; Shu H; Ye Q; Xie C; Yuan B; Zhang Z; Bai F
J Alzheimers Dis; 2017; 56(2):491-507. PubMed ID: 28035927
[TBL] [Abstract][Full Text] [Related]
25. Lack of neural compensatory mechanisms of BDNF val66met met carriers and APOE E4 carriers in healthy aging, mild cognitive impairment, and Alzheimer's disease.
Gomar JJ; Conejero-Goldberg C; Huey ED; Davies P; Goldberg TE;
Neurobiol Aging; 2016 Mar; 39():165-73. PubMed ID: 26923413
[TBL] [Abstract][Full Text] [Related]
26. Butyrylcholinesterase K and Apolipoprotein E-ɛ4 Reduce the Age of Onset of Alzheimer's Disease, Accelerate Cognitive Decline, and Modulate Donepezil Response in Mild Cognitively Impaired Subjects.
De Beaumont L; Pelleieux S; Lamarre-Théroux L; Dea D; Poirier J;
J Alzheimers Dis; 2016 Oct; 54(3):913-922. PubMed ID: 27567841
[TBL] [Abstract][Full Text] [Related]
27. The Effect of the APOE Genotype on Individual BrainAGE in Normal Aging, Mild Cognitive Impairment, and Alzheimer's Disease.
Löwe LC; Gaser C; Franke K;
PLoS One; 2016; 11(7):e0157514. PubMed ID: 27410431
[TBL] [Abstract][Full Text] [Related]
28. The Combined Effect of APOE and BDNF Val66Met Polymorphisms on Spatial Navigation in Older Adults.
Laczó J; Cechova K; Parizkova M; Lerch O; Andel R; Matoska V; Kaplan V; Matuskova V; Nedelska Z; Vyhnalek M; Hort J
J Alzheimers Dis; 2020; 78(4):1473-1492. PubMed ID: 33325388
[TBL] [Abstract][Full Text] [Related]
29. Genetic Risk for Age-Related Cognitive Impairment Does Not Predict Cognitive Performance in Middle Age.
Korthauer LE; Awe E; Frahmand M; Driscoll I
J Alzheimers Dis; 2018; 64(2):459-471. PubMed ID: 29865048
[TBL] [Abstract][Full Text] [Related]
30. The role of clusterin, complement receptor 1, and phosphatidylinositol binding clathrin assembly protein in Alzheimer disease risk and cerebrospinal fluid biomarker levels.
Schjeide BM; Schnack C; Lambert JC; Lill CM; Kirchheiner J; Tumani H; Otto M; Tanzi RE; Lehrach H; Amouyel P; von Arnim CA; Bertram L
Arch Gen Psychiatry; 2011 Feb; 68(2):207-13. PubMed ID: 21300948
[TBL] [Abstract][Full Text] [Related]
31. APOEɛ4 Gene Dose and Sex Effects on Alzheimer's Disease MRI Biomarkers in Older Adults with Mild Cognitive Impairment.
Hobel Z; Isenberg AL; Raghupathy D; Mack W; Pa J;
J Alzheimers Dis; 2019; 71(2):647-658. PubMed ID: 31424388
[TBL] [Abstract][Full Text] [Related]
32. An Alzheimer's Disease Genetic Risk Score Predicts Longitudinal Thinning of Hippocampal Complex Subregions in Healthy Older Adults.
Harrison TM; Mahmood Z; Lau EP; Karacozoff AM; Burggren AC; Small GW; Bookheimer SY
eNeuro; 2016; 3(3):. PubMed ID: 27482534
[TBL] [Abstract][Full Text] [Related]
33. Association between Cerebrospinal Fluid Biomarkers for Alzheimer's Disease, APOE Genotypes and Auditory Verbal Learning Task in Subjective Cognitive Decline, Mild Cognitive Impairment, and Alzheimer's Disease.
Mandecka M; Budziszewska M; Barczak A; Pepłońska B; Chodakowska-Żebrowska M; Filipek-Gliszczyńska A; Nesteruk M; Styczyńska M; Barcikowska M; Gabryelewicz T
J Alzheimers Dis; 2016 Jul; 54(1):157-68. PubMed ID: 27472875
[TBL] [Abstract][Full Text] [Related]
34. Vascular Health and Genetic Risk Affect Mild Cognitive Impairment Status and 4-Year Stability: Evidence From the Victoria Longitudinal Study.
DeCarlo CA; MacDonald SW; Vergote D; Jhamandas J; Westaway D; Dixon RA
J Gerontol B Psychol Sci Soc Sci; 2016 Nov; 71(6):1004-1014. PubMed ID: 26362601
[TBL] [Abstract][Full Text] [Related]
35. Frailty effects on non-demented cognitive trajectories are moderated by sex and Alzheimer's genetic risk.
Thibeau S; McDermott K; McFall GP; Rockwood K; Dixon RA
Alzheimers Res Ther; 2019 Jun; 11(1):55. PubMed ID: 31221191
[TBL] [Abstract][Full Text] [Related]
36. Associations of polymorphisms in the candidate genes for Alzheimer's disease BIN1, CLU, CR1 and PICALM with gestational diabetes and impaired glucose tolerance.
Vacínová G; Vejražková D; Lukášová P; Lischková O; Dvořáková K; Rusina R; Holmerová I; Vaňková H; Včelák J; Bendlová B; Vaňková M
Mol Biol Rep; 2017 Apr; 44(2):227-231. PubMed ID: 28316001
[TBL] [Abstract][Full Text] [Related]
37. The Influence of BDNF Val66Met Polymorphism on Cognition, Cerebrospinal Fluid, and Neuroimaging Markers in Non-Demented Elderly.
Xia H; Wang M; Li JQ; Tan CC; Cao XP; Tan L; Yu JT;
J Alzheimers Dis; 2019; 68(1):405-414. PubMed ID: 30775992
[TBL] [Abstract][Full Text] [Related]
38. Analysis of cognitive performance and polymorphisms of SORL1, PVRL2, CR1, TOMM40, APOE, PICALM, GWAS_14q, CLU, and BIN1 in patients with mild cognitive impairment and cognitively healthy controls.
Cruz-Sanabria F; Bonilla-Vargas K; Estrada K; Mancera O; Vega E; Guerrero E; Ortega-Rojas J; Mahecha María F; Romero A; Montañés P; Celeita V; Arboleda H; Pardo R
Neurologia (Engl Ed); 2021; 36(9):681-691. PubMed ID: 34752346
[TBL] [Abstract][Full Text] [Related]
39. Association of CR1, CLU and PICALM with Alzheimer's disease in a cohort of clinically characterized and neuropathologically verified individuals.
Corneveaux JJ; Myers AJ; Allen AN; Pruzin JJ; Ramirez M; Engel A; Nalls MA; Chen K; Lee W; Chewning K; Villa SE; Meechoovet HB; Gerber JD; Frost D; Benson HL; O'Reilly S; Chibnik LB; Shulman JM; Singleton AB; Craig DW; Van Keuren-Jensen KR; Dunckley T; Bennett DA; De Jager PL; Heward C; Hardy J; Reiman EM; Huentelman MJ
Hum Mol Genet; 2010 Aug; 19(16):3295-301. PubMed ID: 20534741
[TBL] [Abstract][Full Text] [Related]
40. Genetics of Alzheimer's disease: new evidences for an old hypothesis?
Lambert JC; Amouyel P
Curr Opin Genet Dev; 2011 Jun; 21(3):295-301. PubMed ID: 21371880
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
